Novel therapies in development that inhibit motor neuron hyperexcitability in amyotrophic lateral sclerosis.

about

Drugs in clinical development for the treatment of amyotrophic lateral sclerosis.Neuronal hyperexcitability in a mouse model of SCN8A epileptic encephalopathy.Current Advances and Limitations in Modeling ALS/FTD in a Dish Using Induced Pluripotent Stem Cells.

P2860

Q38748144-4694488D-0D46-4B68-A5E6-A6C061097364 Q38757993-1168DD63-D550-4DF3-B21E-9ABD5414F5E2 Q47868914-629F610B-567A-4265-995E-67310C81FBBA

P2860

Novel therapies in development that inhibit motor neuron hyperexcitability in amyotrophic lateral sclerosis.

Item

http://www.wikidata.org/entity/Q38868221

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Novel therapies in development ...... amyotrophic lateral sclerosis.

@en

type

Item

label

Novel therapies in development ...... amyotrophic lateral sclerosis.

@en

prefLabel

Novel therapies in development ...... amyotrophic lateral sclerosis.

@en

P1476

Novel therapies in development ...... amyotrophic lateral sclerosis.

@en

P2093

Kazumoto Shibuya

http://www.w3.org/2001/XMLSchema#string

Yu-Ichi Noto

http://www.w3.org/2001/XMLSchema#string

P2860

Riluzole for amyotrophic lateral sclerosis (ALS)/motor neuron disease (MND)

Neural KCNQ (Kv7) channels

Focality, stochasticity and neuroanatomic propagation in ALS pathogenesis

Pathobiology of ischaemic stroke: an integrated view

Aberrant RNA processing in a neurodegenerative disease: the cause for absent EAAT2, a glutamate transporter, in amyotrophic lateral sclerosis

Edaravone, a Free Radical Scavenger, Delayed Symptomatic and Pathological Progression of Motor Neuron Disease in the Wobbler Mouse

Induced pluripotent stem cells generated from patients with ALS can be differentiated into motor neurons

Modeling key pathological features of frontotemporal dementia with C9ORF72 repeat expansion in iPSC-derived human neurons

Calbindin D-28k and parvalbumin immunoreactivity in the frontal cortex in patients with frontal lobe dementia of non-Alzheimer type associated with amyotrophic lateral sclerosis.

D-serine is a key determinant of glutamate toxicity in amyotrophic lateral sclerosis

P304

1147-1154

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1080/14737175.2016.1197774

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Matthew C Kiernan

Steve Vucic

P577

2016-06-17T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27314534

http://www.w3.org/2001/XMLSchema#string

P921

amyotrophic lateral sclerosis

Novel therapies in development that inhibit motor neuron hyperexcitability in amyotrophic lateral sclerosis.

about

P2860

P2860

Novel therapies in development that inhibit motor neuron hyperexcitability in amyotrophic lateral sclerosis.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P921

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P921